| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83521 |
DOTA-TRIS(TBE)-AMIDO DPEG 11-MALEIMIDE 基于NOTADOTA定制偶联 |
111 |
zcy |
2024-11-29 |
| 83522 |
1226909-66-5，DLin-M-C4-DMA |
86 |
kx |
2024-11-29 |
| 83523 |
3,6-二苯甲酸-1,2,4,5-四嗪,4,4'-(1,2,4,5-Tetrazine-3,6-diyl)dibenzoic acid |
106 |
WYQ |
2024-11-29 |
| 83524 |
DOTA-tris(t-Bu)-Amido-PEG23-Bromoacetamide DOTA-聚乙二醇（PEG）间隔基-溴乙酰胺 |
105 |
zcy |
2024-11-29 |
| 83525 |
L-4-四嗪—苯丙氨酸,L-4-Tetrazine-phenylalanine |
119 |
WYQ |
2024-11-29 |
| 83526 |
六酯基-O6-冠[3]芳烃[3]四嗪,Hexester-O6-corona[3]arene[3]tetrazine（ |
135 |
WYQ |
2024-11-29 |
| 83527 |
3，6-二甲基-六氢-s-四嗪,也可称为3，6-二甲基-1，4-二氢-S-四嗪 |
137 |
WYQ |
2024-11-29 |
| 83528 |
3，6-二（对氯苄基）-s-四嗪 |
102 |
WYQ |
2024-11-29 |
| 83529 |
3，6-二（对氯苯基）-s-四嗪 |
109 |
WYQ |
2024-11-29 |
| 83530 |
1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-硝氨基)含能离子盐 |
117 |
WYQ |
2024-11-29 |
| 83531 |
三环化合物1,4-二氢-1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-氨基) |
198 |
WYQ |
2024-11-29 |
| 83532 |
四嗪基团封端的四臂聚乙二醇（Tz-PEG） |
139 |
WYQ |
2024-11-29 |
| 83533 |
Azido-mono-amide-DOTA ，叠氮基-单-酰胺-DOTA |
105 |
wyh |
2024-11-29 |
| 83534 |
Iron DOTA Sodium Salt, 5 mg 铁DOTA钠盐 |
104 |
zcy |
2024-11-29 |
| 83535 |
DOTA-TATE ， DOTA-3-酪氨酰基-奥曲肽 , 177943-89-4 |
182 |
wyh |
2024-11-29 |
| 83536 |
2570254-31-6，Pomalidomide-C3-I |
97 |
kx |
2024-11-29 |
| 83537 |
1262403-91-7 , 七肽DOTA-YLYEIAR |
107 |
wyh |
2024-11-29 |
| 83538 |
DOTA-amide dihydrate；DOTA酰胺二水合物 |
107 |
zcy |
2024-11-29 |
| 83539 |
RGD,[18F]FB-c(RGDyK) , N-4-[18F]Fluorobenzoyl-c(RGDyK |
120 |
wyh |
2024-11-29 |
| 83540 |
1262403-90-6 , 七肽DOTA-VLASSAR |
104 |
wyh |
2024-11-29 |
| 83541 |
486429-99-6，(S)-C3-TunePhos |
124 |
kx |
2024-11-29 |
| 83542 |
海藻酸钠-聚乙二醇-大环配体 ；alginate-PEG-DOTAM |
136 |
wyh |
2024-11-29 |
| 83543 |
DOTA-三叔丁酯-叠氮 ；DOTA-(COOt-Bu)3-azide |
152 |
wyh |
2024-11-29 |
| 83544 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 DOTA-PEG5-C4-DBCO |
114 |
zcy |
2024-11-29 |
| 83545 |
1539292-60-8，APN-C3-NH-Boc |
123 |
kx |
2024-11-29 |
| 83546 |
DOTA-cyclo(Arg-Gly-Asp-DPhe-Lys) |
107 |
wyh |
2024-11-29 |
| 83547 |
DOTA-TMTP1的性质与应用 |
97 |
wyh |
2024-11-29 |
| 83548 |
DOTA-三聚乙二醇-叠氮(盐酸盐) DOTA-PEG3-azide(HCl) 1428146-79-5 |
96 |
zcy |
2024-11-29 |
| 83549 |
7-R-7-磷杂降冰片二烯M(CO)5(M=Mo,W)配合物 |
220 |
h |
2024-11-29 |
| 83550 |
DOTA-cyclo(RGDfK) ；DOTA-RGD |
148 |
wyh |
2024-11-29 |
| 83551 |
2376146-48-2，ZN-c3 |
115 |
kx |
2024-11-29 |
| 83552 |
Mem-Tz-Rh 四嗪与罗丹明结构连接溶酶体靶向探针 |
162 |
WYQ |
2024-11-29 |
| 83553 |
Mito-Tz-BDP Bodipy与四嗪共轭连接线粒体靶向探针 |
214 |
WYQ |
2024-11-29 |
| 83554 |
3-三氟甲基-6-硝基胍基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
126 |
WYQ |
2024-11-29 |
| 83555 |
DOTA-「Tyr3」-Octreotide , DOTA-(酪氨酸3)-奥曲肽 |
93 |
wyh |
2024-11-29 |
| 83556 |
1,4-二吡唑基-2,3,5,6-四嗪构筑的金属有机框架 |
134 |
WYQ |
2024-11-29 |
| 83557 |
1,4-二-(吡唑基)-2,3,5,6-四嗪修饰三氟甲基磺酸锌[Zn(bptz)2]n |
183 |
WYQ |
2024-11-29 |
| 83558 |
3,6-二(4-吡啶基)-1,2,4,5-四嗪 |
99 |
WYQ |
2024-11-29 |
| 83559 |
DOTA-PEG4-MeTz DOTA-PEG4-甲基四嗪 甲基四嗪聚乙二醇大环化合物 |
147 |
zcy |
2024-11-29 |
| 83560 |
5966-29-0；N-棕榈酰-D-赤型-鞘氨醇；C16 Dihydroceramide (d18:0/16:0) |
409 |
kx |
2024-11-29 |
| 83561 |
p-SCN-Bn-DOTA ；2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
108 |
wyh |
2024-11-29 |
| 83562 |
DOTA-Suc-Lys-(FAPI-04)2 3029114-60-8 DOTA-琥珀酰基-赖氨酸-(FAPI-04)2 |
118 |
zcy |
2024-11-29 |
| 83563 |
913528-04-8 , DOTAM-mono-acid-CSDN |
85 |
wyh |
2024-11-29 |
| 83564 |
降冰片烯单体[5-降冰片烯-2-亚甲氧基-4-己氧基联苯(PhHN)] |
166 |
h |
2024-11-29 |
| 83565 |
Tm-DOTA , DOTA大环化合物 |
96 |
wyh |
2024-11-29 |
齐岳微信公众号
官方微信
库存查询